Author

S. P. Keeler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

M. J. Holtzman· 3 shared K. Wu· 2 shared A. G. Romero· 1 shared A. L. Bailey· 1 shared A. O. Hassan· 1 shared A. S. Kim· 1 shared A. Schaefer· 1 shared A. W. Wessel· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. J. Holtzman

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production

S. P. Keeler, K. Wu, Y. Zhang, D. Mao, M. Li, C. A. Iberg, S. R. Austin, S. A. Glaser, J. Yantis, S. Podgorny, S. L. Brody, J. R. Chartock, Z. Han, D. E. Byers, A. G. Romero, M. J. Holtzman

This paper develops a potent MAPK13-14 inhibitor, NuP-3, which reduces airway inflammation and mucus production in human airway models and minipig disease models.

bioRxiv · May 26, 2023Immunology

An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease

R. A. Martin, S. P. Keeler, K. Wu, W. J. Shearon, D. Patel, M. Hoang, C. M. Hoffmann, M. E. Hughes, M. J. Holtzman

This study identifies a distinct pattern of skeletal muscle dysfunction in a mouse model of long-term post-viral lung disease caused by Sendai virus, showing reduced myofiber size without changes in myofiber type or protein synthesis/degradation markers.

bioRxiv · Oct 7, 2022Physiology

A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection

A. O. Hassan, N. M. Kafai, I. P. Dmitriev, J. M. Fox, B. Smith, I. B. Harvey, R. E. Chen, E. S. Winkler, A. W. Wessel, J. B. Case, E. Kashentseva, B. T. McCune, A. L. Bailey, H. Zhao, L. A. VanBlargan, , M. S. Diamond

A single intranasal dose of ChAd-SARS-CoV-2-S vaccine prevents SARS-CoV-2 infection and likely confers sterilizing immunity in mice.

bioRxiv · Jul 16, 2020 · PreprintMicrobiology